C07K 14/70557
Integrin beta3-subunit-containing molecules
Official title: {Integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61}
C07K14/70557 (Integrin beta3-subunit-containing molecules) appears on 81 US grants and 68 published applications in this corpus.
Search patents in C07K- Granted patents
- 81
- Published applications
- 68
- Assignees
- 42
- Inventors
- 157
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 0 | 0 |
| 1995 | 5 | 0 |
| 1996 | 4 | 0 |
| 1997 | 7 | 0 |
| 1998 | 9 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 6 |
| 2003 | 2 | 2 |
| 2004 | 1 | 5 |
| 2005 | 1 | 4 |
| 2006 | 2 | 1 |
| 2007 | 0 | 1 |
| 2008 | 4 | 2 |
| 2009 | 3 | 2 |
| 2010 | 0 | 2 |
| 2011 | 1 | 1 |
| 2012 | 1 | 3 |
| 2013 | 3 | 2 |
| 2014 | 2 | 3 |
| 2015 | 3 | 0 |
| 2016 | 0 | 3 |
| 2017 | 1 | 2 |
| 2018 | 2 | 3 |
| 2019 | 0 | 2 |
| 2020 | 2 | 4 |
| 2021 | 1 | 7 |
| 2022 | 2 | 5 |
| 2023 | 0 | 2 |
| 2024 | 1 | 2 |
| 2025 | 2 | 1 |
| 2026 | 6 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Peptides and methods of treating sepsis, atherosclerosis, thrombosis, stroke, heart attack and inflammation25 Aug 2026US 12,714,678 B2The Board of Trustees of the University of Illinois
- Integrin-targeting protein and methods of use thereof16 Jun 2026US 12,655,197 B2Georgia State University Research Foundation, Inc.
- Methods for treating drug resistant cancers14 Apr 2026US 12,601,743 B2The Regents of the University of California
- Integrin targeting ligands and uses thereof24 Mar 2026US 12,582,718 B2Arrowhead Pharmaceuticals, Inc.
- Alternative intracellular signalling domain of a chimeric antigen receptor3 Feb 2026US 12,540,169 B2
- Compositions and methods for assessing, treating, or reducing aging-related functional decline11 Jun 2026US 2026/0158073 A1Children's Medical Center Corporation
- P-selectin mutants and modulation of integrin-mediated signaling21 May 2026US 2026/0139028 A1The Regents of the University of California
- 68ga- and 64cu -nodaga-e[c(rgdyk)]2 for use as pet tracers in the imaging of angiogenesis in humans23 Apr 2026US 2026/0108638 A1Rigshospitalet
- Fused in sarcoma (fus) nuclear translocation inhibitors for preventing fibrosis6 Feb 2025US 2025/0042959 A1The United States AS Represented By the Department of Veterans Affairs
- Method for Stimulating the Gene Expression in Endometrial Cells4 Jul 2024US 2024/0218349 A1Telea Electronic Engineering S.r.l.
Most cited
By later US patents
- Polymorphism of human platelet membrane glycoprotein IIIa and diagnostic and therapeutic applications thereof77US 5,091,302 AThe Blood Center of Southeastern Wisconsin · 1992
- Methods and compositions useful for inhibition of angiogenesis77US 5,753,230 AThe Scripps Research Institute · 1998
- Methods and compositions useful for inhibition of angiogenesis77US 5,766,591 AThe Scripps Research Institute · 1998
- Method and composition for treating thrombosis62US 5,672,585 ALa Jolla Cancer Research Foundation · 1997
- Peptides and antibodies that inhibit integrin-ligand binding49US 5,149,780 AThe Scripps Research Institute · 1992